Stock Market News

Hoth Therapeutics stock rises after positive Phase 2a trial results

Jun 24, 2025 - 16:18
 0
Hoth Therapeutics stock rises after positive Phase 2a trial results
Read More

Tags:

Previous Article

Powell: Fed sees potential for rate cuts later this year

Next Article

Israel stocks higher at close of trade; TA 35 up 1.26%

Related Posts

Caris Life Sciences Raises Price Range of 23.53M Share IPO at $19-$20/sh

Caris Life Sciences Raises Price Range of 23.53M Share ...

Jun 16, 2025  0

Malaysia says verifying reports of Chinese firm using Nvidia AI chips

Malaysia says verifying reports of Chinese firm using N...

Jun 18, 2025  0

Oracle: Jefferies hikes PT on upbeat earnings, accelera...

Jun 12, 2025  0